跳至主要内容
临床试验/TCTR20200827002
TCTR20200827002Enrolling By Invitation未知

Comparison between using hepatocellular carcinoma (HCC) risk scores and current criteria to identify chronic hepatitis B patients needing HCC surveillance

one0 个研究点目标入组 201 人开始时间: 2020年8月27日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
发起方
one
入组人数
201

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Chronic hepatitis B patients between age of 18-80 years that follow up and treatment under the Thai Chronic hepatitis B guideline 2015

排除标准

  • 1.Chronic hepatitis B patient with hepatocellular carcinoma
  • 2.Chronic hepatitis B with HIV infection
  • 3.Chronic hepatitis B with chronic hepatitis C infection
  • 4.Post liver transplantation patients
  • 4.Decompensated liver cirrhosis without waiting list for liver transplantation
  • 5.The patients had history of chronic alcoholic drinking more tham 40-80 gram per day in male or 20-40 gram per day in female
  • 6.The patients who had herbal medicine or drug abuse
  • 7.Chronic hepatitis B patients with autoimmune hepatitis
  • 8.Chronic heoatitis B patients with non-alcoholic steatohepatitis

研究者

发起方
one

相似试验

Comparison between using hepatocellular carcinoma... | 临床试验